SeroState (serostate.com) is a behavioral health technology company. Post-session evidence infrastructure, not prostate or urology medicine.
The name refers to physiological session state in behavioral care. We fuse wearable biosignal and vocal biomarkers into audit-ready FHIR R4 evidence via the QOAX API.
Behavioral health has no objective physiological standard in the chart. Oncology has imaging, cardiology has ECG, and behavioral health still runs on self-report.
We are obsessed with one problem:
surfacing physiological warnings of deterioration,
visible in the record, post-session.
When the two devastating earthquakes hit Hatay, deterioration went unseen by the experts. Not because they were inexperienced: they were affected themselves, there was no time for supervision, and their determination to help meant they would not leave the disaster zone. The longer they worked without anyone watching over the work, the worse the outcomes became. Support stopped landing, and most survivors never built trust in the psychologists trying to help them.
Everyone was doing the right job. But because there was no objective measure of the care being given, the few who actually felt better were simply the ones lucky enough to build a bond with their expert. Chance is not a clinical standard.
Later I found the same gap at the top of the system. The World Health Organization recommends that mental health services be part of medical care, and that care for noncommunicable diseases integrate mental health as well. Both are the right calls, and neither comes with an objective measure of whether the care is working. There was no tool to make that possible for the people in healthcare, in mental care, or in the therapy room.
These are the reasons we left our professional careers and jumped into the ocean: to make this technology available where it touches lives, and to support experts in making their work stronger. That is why we are building SeroState.
SeroState (serostate.com) is a behavioral health technology company. It produces post-session physiological evidence (wearable biosignal and vocal biomarkers fused into audit-ready FHIR R4 records) and delivers it via the QOAX REST API to EHR and RPM platforms.
No. SeroState is not related to prostate health, urology, or PSA testing. The name refers to physiological session state in behavioral care. SeroState is an API-first company serving behavioral health, RPM, and EHR platforms. Product details live at serostate.com.
AI scribe platforms focus on transcription and note generation. SeroState fuses voice with wearable physiology into confidence-scored evidence. It supports reimbursement documentation and audit defense; it does not replace the scribe.
Behavioral health platforms, RPM vendors, and EHR integrators that need objective physiological evidence alongside session documentation, embedded in existing stacks via the QOAX API.
Audio-only = documentation mode. Wearable unlocks audit-defensible CPT corroboration. Clinician sign-off required.
Redacted sample report, fusion engine, arousal scoring, and evidence confidence.
Published literature per signal, our validation method and honest limitations.
Endpoints, response shape, and integration model.
Leakage zone vs. evidence zone: CPT gap recovery.
HIPAA, 42 CFR Part 2, and audit-trail architecture.
Integration scope and partnership economics for RPM and EHR platforms.